Disclosed are methods of treating anti-inflammatory discase or conditions,typically by orally administeringencochleated anti-inflammatory agents, including NSAIDS. Orally administeredcochleates have significantly reduced toxicity as comparedto non-encochleated anti-inflammatory agents.